|Articles|July 16, 2019

OmniComm Systems to be Acquired by Anju Software

OmniComm Systems, Inc. has announced that it has entered into a merger agreement with Anju Software, Inc., under which OmniComm will become a wholly owned subsidiary of Anju. The closing is expected to occur by October 31, 2019 following the satisfaction of customary closing conditions.

Find more details of the aquisition, right here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

OmniComm Systems to be Acquired by Anju Software

Newsletter

Related Content

Reducing Site Burden Through Better Technology Integration in Clinical Trials

Broad Survival Benefit from MATTERHORN Trial Highlights New Approach to Biomarker Use

Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials

Trending on Applied Clinical Trials Online

Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development

Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

Reducing Site Burden Through Better Technology Integration in Clinical Trials

Broad Survival Benefit from MATTERHORN Trial Highlights New Approach to Biomarker Use